Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Clinical trial NCT00883675 · COMPLETED

Trial details

NCT number: NCT00883675
Sponsor: Michael Mann
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2009-05-01
Primary completion: 2012-09-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.